Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate Tuberculosis Subunit Vaccine

The development of a vaccine against tuberculosis (TB), a disease caused by Mycobacterium tuberculosis, is urgently needed. The only currently available vaccine, M. bovis BCG, has variable efficacy. One approach in the global vaccine development effort is focused on boosting BCG using subunit vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Stylianou, Elena, Harrington-Kandt, Rachel, Beglov, Julia, Bull, Naomi, Pinpathomrat, Nawamin, Swarbrick, Gwendolyn M., Lewinsohn, Deborah A., Lewinsohn, David M., McShane, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Microbial Immunity and Vaccines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013653/
https://www.ncbi.nlm.nih.gov/pubmed/29661928
http://dx.doi.org/10.1128/IAI.00014-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013653/
https://www.ncbi.nlm.nih.gov/pubmed/29661928
http://dx.doi.org/10.1128/IAI.00014-18

Ejemplares similares